Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenalidomide, Dexamethasone, and Clarithromycin Maintenance in Multiple Myeloma
NCT00445692Phase 2Completed
- Sponsor
- Fred Hutchinson Cancer Center
- Start
- Jan 2007
- Primary completion
- Apr 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lenalidomide, clarithromycin in multiple myeloma (MM), sponsored by Fred Hutchinson Cancer Center. Started Jan 2007; status: completed.
02
Drugs
lenalidomideclarithromycin
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT00445692.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00445692.